Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
Status:
Recruiting
Trial end date:
2025-09-04
Target enrollment:
Participant gender:
Summary
This phase II trial studies how well lutathera works in treating patients with meningioma
that cannot be treated with surgery (inoperable) and is growing, spreading, or getting worse
(progressive) after external beam radiation therapy. Lutathera is a radioactive drug
administered in the vein that is designed to target and kill cancer cells. The goal of this
study is to determine whether this drug is safe and effective in treating meningiomas that
progress after radiation treatment.